Bacillus atrophaeus

PTCC No: 
1670
Other collection No. :: 
DSM 675, ATCC 9372
Culture condition: 
30 °C
Information: 
<- DSMZ <- BMTU <- ATCC <- N.R. Smith, 1221A (Bacillus subtilis var. niger) <- Bacon Labs. (Bacillus globigii, red strain) <- C.R. Phillips <- E. McCoy. Until 2000 listed under Bacillus subtilis. Synonym: Bacillus subtilis var. niger.Used for resistance testing, efficacy testing, ethylene oxide sterilization control, media testing, sterility assurance, sterilization control. Biological indicator for hot air sterlization control. produces L-desoxynojirimycin, inhibitor for glocoside hydrolases.
Literature: 

Resistance testing (Clothing for protection against infectious agents --- Test method for resistance to dry microbial penetration. London, UK:British Standards Institution; British Standard BS EN ISO 22612:2005). Dry heat sterilization control (British Pharmacopoeia Commission Methods of sterilization. London, UK:British Pharmacopoeia Commission, British Pharmacopoeia Appendix XVIII, 2003; European Pharmacopoeia Commission Biological indicators of sterilization. Strasbourg, France:European Pharmacopoeia Commission, European Pharmacopoeia EP 5.1.2, 1997; U.S. Pharmacopeia USP Monographs: Biological Indicator for Dry-heat Sterilization, Paper Carrier. Rockville, MD: U.S. Pharmacopeia, USP USP34-NF29, 2011). Efficacy testing (Standard Test Method for Determination of Effectiviness of Cleaning Processes for Reusable Medical Instruments Using a Microbiologic Method (Simulated Use Test). West Conshohocken, PA:ASTM International, ASTM Standard Test Method E 2314-03; Standard Test Method for Quantitative Sporicidal Three-Step Method (TSM) to Determine Sporicidal Efficacy of Liquids, Liquid Sprays, and Vapor or Gases on Contaminated Carrier Surfaces. West Conshohocken, PA:ASTM International, ASTM Standard Test Method E 2414-05). Ethylene oxide sterilization control (British Pharmacopoeia Commission Methods of sterilization. London, UK:British Pharmacopoeia Commission, British Pharmacopoeia Appendix XVIII, 2003; European Pharmacopoeia Commission Biological indicators of sterilization. Strasbourg, France:European Pharmacopoeia Commission, European Pharmacopoeia EP 5.1.2, 1997; .S. Pharmacopeia USP Monographs: Biological Indicator for Ethylene Oxide Sterilization, Paper Carrier. Rockville, MD:U.S. Pharmacopeia, USP USP34-Nf29, 2011). Media testing (Microbial Ranking of Porous Packaging Materials (Exposure Chamber Method). Gaithersburg, MD:AOAC International; AOAC, Official Methods of Analysis of the AOAC International, 997.17). Sterility assurance (Terminal Sterilization and Sterilization Indicators. Tokyo, Japan:Japanese Pharmacopoeia, JP JP14e.part II.15; Sterilization of health care products--Biological indicators--Part 2: Biological indicators for ethylene oxide sterilization. Geneva (Switzerland):International Organization for Standardization/ANSI, ISO ISO 11138-2:1994; Sterilization of single-use medical devices incorporating materials of animal origin--Validation and routine control of sterilization by liquid chemical sterilants. Geneva (Switzerland):International Organization for Standardization/ANSI, ISO ISO 14160:1998; Sterilization of single-use medical devices incorporating materials of animal origin --- Validation and routine control of sterilization by liquid chemical sterilants, Annex A. London, UK:British Standards Institution, British Standard BS EN ISO 14160:1998). Sterilization control (Sterilization of health care products --- Biological indicators, Part 2: Biological indicators for ethylene oxide sterilization processes. London, UK:British Standards Institution, British Standard BS EN ISO 11138-2:2006; Sterilization of health care products --- Biological indicators, Part 4: Biological indicators for dry heat sterilization processes. London, UK:British Standards Institution, British Standard BS EN ISO 11138-4:2006). Taxonomy (Int J Syst Evol Microbiol 2001, 51:35-37; Appl Environ Microbiol 2004, 70:2786-2790). Production of L-desoxynojirimycin and inhibitors for glocoside hydrolases (Frommer,W. (1981) Inhibitors, obtained from bacilli, for glycoside hydrolases. Brit. Pat. 155,409)

Supplied as: 
Freeze-dried
Risk group: 
1